Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04370691 · ClinicalTrials.gov registry record
JETi Lower Extremity Arterial Thrombosis
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 129
- Enrollment target
NCT04370691 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 129 participants.
The verdict
NCT04370691 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 129 participants
- Enrollment target
Study Summary
The JETi Registry is a prospective, single-arm, multi-center study to collect real-world data on the safety, performance, and clinical benefits of the JETi™ Hydrodynamic Thrombectomy System (JETi System) for the treatment of acute/subacute thrombosis in the peripheral vasculature. This post-market study will register approximately 280 subjects at approximately 30 centers Globally. Subjects participating in this Registry will be followed through their 12-month follow up visit.
Interventions
- DEVICE JETi lower extremity arterial thrombosis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2020-03-06 |
| Est. Completion | 2024-10-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04370691
The ClinicalTrials.gov registry entry for NCT04370691 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which JETi lower extremity arterial thrombosis is the first listed.
NCT04370691 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04370691 about?
NCT04370691 is a clinical study titled "JETi Lower Extremity Arterial Thrombosis". The JETi Registry is a prospective, single-arm, multi-center study to collect real-world data on the safety, performance, and clinical benefits of the JETi™ Hydrodynamic Thrombectomy System (JETi System) for the treatment of acute/subacute thrombosis in the peripheral vasculature. This post-market s...
What is the current status of trial NCT04370691?
This trial is currently completed. The enrollment target is 129 participants. The study started on 2020-03-06. Estimated completion is 2024-10-09.
What interventions are being tested in trial NCT04370691?
The interventions under investigation include: JETi lower extremity arterial thrombosis (DEVICE).
Who is sponsoring clinical trial NCT04370691?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.